Latest posts tagged with #TCSC on Bluesky
The KEYNOTE-B96 trial reported an improvement in overall survival and progression-free survival, marking one of the most promising advances for patients with platinum-resistant ovarian cancer.
#CancerBreakthrough #OncologyResearch #HopeInScience #TCSC
A major phase 3 trial shows Keytruda combined with weekly paclitaxel improved survival for patients with platinum-resistant ovarian cancer, offering a potential new option where treatments have long been limited.
#OvarianCancer #Immunotherapy #ClinicalTrials #TCSC
www.curetoday.com/view/keytrud...
Over 400 clinical trials are already exploring cancer vaccines as potential treatments. If successful, they could transform how we prevent recurrence and treat tumors in the future.
#CancerScience #ClinicalTrials #FutureOfMedicine #TCSC
Cancer vaccines are no longer science fiction. Researchers say the field is accelerating fast, with hundreds of trials exploring how vaccines could train the immune system to fight cancer.
#immunotherapy
#CancerResearch #MedicalInnovation #TCSC
news.northeastern.edu/2026/03/13/c...
From CAR-T approaches to bispecific antibodies, scientists are learning how to guide immune cells directly to cancer. Each clinical trial moves the field a little closer to better, more precise treatments.
#CancerTrials #PrecisionMedicine #CancerScience #TCSC
The momentum behind immunotherapy continues to build. Researchers are exploring CAR-T and bispecific T-cell therapies designed to help the immune system attack prostate cancer more effectively.
#Immunotherapy #CancerInnovation #CancerResearch #Oncology #TCSC
cancerletter.com/sponsored-ar...
Combining therapies is becoming one of the most powerful strategies in oncology. By activating the immune system while targeting the tumour directly, researchers hope to improve outcomes in early-stage prostate cancer.
#CancerInnovation #Immunotherapy #CancerScience #TCSC
Encouraging news in prostate cancer research: pairing next-generation immunotherapy with standard hormone therapy before surgery may help overcome long-standing treatment barriers.
#ProstateCancer #Immunotherapy #CancerResearch #Oncology #TCSC
cancerletter.com/the-cancer-l...
Up to 75% of patients report cognitive issues during chemotherapy. Studies like this show supportive care matters just as much as drugs. Exercise may become part of routine cancer care in the future.
#CancerCare #CancerTreatment #OncologyResearch #TCSC
New research suggests something remarkably simple may help reduce “chemo brain.” A structured program of walking and resistance exercises helped patients stay mentally sharper during chemotherapy.
#CancerResearch #ChemoBrain #Oncology #CancerSupport #TCSC
www.urmc.rochester.edu/news/story/c...
Pancreatic cancer is often diagnosed late, making it difficult to treat. Targeting early cellular changes before cancer develops could transform how the disease is prevented and treated. #CancerResearch #EarlyDetection #TCSC
A new research strategy aims to stop #pancreaticcancer before tumours even form. Scientists are exploring ways to eliminate microscopic precancerous lesions, potentially preventing this cancer from developing. #PancreaticCancer #MedicalInnovation #TCSC
www.eurekalert.org/news-release...
BPDCN is a rare blood cancer with limited treatment options. Results like these from early trials offer hope that new targeted therapies could soon improve survival and quality of life. #Hematology #ClinicalTrials #TCSC
A promising antibody-drug conjugate therapy is showing encouraging results in a rare #bloodcancer. In an early trial, 75% of patients with BPDCN achieved a complete response with the investigational treatment pivekimab sunirine. #Leukemia #CancerTreatment #TCSC
www.news-medical.net/news/2026021...
Lynch syndrome significantly increases the risk of several cancers, including colorectal and uterine cancers. Early genetic testing and coordinated care can make a life-saving difference. Awareness matters. #CancerAwareness #GeneticTesting #TCSC
A new centre at Penn Medicine aims to transform care for people with inherited cancer risk. The King Center for Lynch Syndrome will combine #genetics, screening and treatment expertise to catch cancers earlier and improve outcomes. #CancerPrevention #PrecisionMedicine #TCSC
whyy.org/articles/lyn...
Triple-negative breast cancer remains one of the toughest cancers to treat. Discoveries like this could open the door to entirely new therapies. #OncologyResearch #PrecisionMedicine #TCSC
Scientists have discovered a new molecule that may stop aggressive triple-negative breast cancer in its tracks. Research suggests it can suppress tumour growth by targeting a key cancer enzyme. #BreastCancer #CancerResearch #DrugDiscovery #TCSC
www.sciencedaily.com/releases/202...
Behind every cancer breakthrough are patients and families whose strength pushes medicine forward. Their stories deserve to be heard. #PatientStories #CancerCommunity #TCSC
A remarkable story of family, courage and medical innovation. At NYU Langone’s Perlmutter Cancer Center, a groundbreaking transplant brought new hope to a mother and her daughter facing cancer together. #CancerCare #MedicalInnovation #Hope #TCSC
nyulangone.org/news/mother-...
Key takeaway: small, sustainable changes to weight, diet, and activity can lower risk over time, especially when combined with screening and early detection. Every step counts. #CancerAwareness #PublicHealth #TCSC
A new JAMA review explains how obesity biologically drives cancer risk… and how targeting inflammation, hormones, and metabolism could improve prevention and treatment. Hope powered by science. #Cancer #Prevention #TCSC
jamanetwork.com/journals/jam...
For patients with residual disease, better post-neoadjuvant options could help reduce recurrence risk and improve outcomes. Progress matters. #Oncology #BreastCancer #TCSC
Enhertu has been granted US Priority Review for HER2-positive early breast cancer after neoadjuvant treatment. A hopeful step forward for patients with residual disease. #BreastCancer #CancerResearch #TCSC
www.astrazeneca.com/media-centre...
Understanding your cancer and the treatments available is one of the most powerful steps a patient can take. Information helps people navigate the journey with greater confidence. #CancerAwareness #PatientAdvocacy #TCSC
Knowledge is power when facing cancer. The Spring 2026 issue of Cancer Health highlights how learning about your diagnosis and treatment options can help patients make more confident decisions about their care. #CancerPatients #CancerCare #HealthEducation #TCSC
www.cancerhealth.com/article/spec...
Cancer treatment is no longer just one tool. Surgery, radiation, chemotherapy and targeted therapies all work together to improve survival and quality of life. Understanding the options empowers patients. #CancerAwareness #TCSC
Chemotherapy has changed dramatically over the years. Today’s treatments are often more targeted, better tolerated and carefully tailored to each patient. #CancerTreatment #Oncology #CancerCare #TCSC
www.mayoclinic.org/tests-proced...
A scientist has explained how eating yoghurt regularly could help reduce the risk of aggressive bowel cancer, with research showing it may protect against certain types of the disease!
#Oncology #breakfast #bowelcancer #TCSC
apple.news/AbCnPHVTVS_y...
Innovation in breast cancer treatment continues to accelerate, bringing fresh hope for patients facing difficult diagnoses and limited options.
#BreastCancerAwareness #Oncology #TCSC
